Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Determinants of Primary Care Health Professionals' Numeracy Skills and Practices and Association With Patient Health Literacy and Quality of Care

Study ID: NCT07379086
Start Date: 2026-06-01
End Date: 2027-11-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

MSPU de Pins-Justaret

Source: clinicaltrials.gov

Share:
Add to list

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Study ID: NCT06303193
Start Date: 2026-02-03
End Date: 2035-01-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

160

Intervention / Treatment

pacritinib

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients

Study ID: NCT06907485
Start Date: 2026-08
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Aminolevulinic acid hydrochloride

Sponsor

Costas Hadjipanayis

Source: clinicaltrials.gov

Share:
Add to list

A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis

Study ID: NCT07020715
Start Date: 2026-03-01
End Date: 2028-10-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

14

Intervention / Treatment

Tolerogenic dendritic cells (tolDC)

Sponsor

University Hospital, Antwerp

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2 Platform Study of Immunomodulatory Compounds in ICI-refractory Non-small Cell Lung Cancer

Study ID: NCT07133425
Start Date: 2026-02-05
End Date: 2030-02-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

29

Intervention / Treatment

SAR445877

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Genitourinary Study of Fostering Lactobacillus to Optimize the Microbiome in Women's Health (GUD-FLORA)

Study ID: NCT07234227
Start Date: 2026-06
End Date: 2028-02
Study Type

Interventional

Study Phase

Phase1

No. of Participants

156

Intervention / Treatment

Lactobacillus crispatus probiotic

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

A Just-in-time Adaptive Intervention for Suicide Safety Planning in Adolescents

Study ID: NCT07348666
Start Date: 2026-02-16
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

ViraSafe: Treatment pushes

BRITE

Sponsor

Ksana Health

Source: clinicaltrials.gov

Share:
Add to list

Effects of Vibration-Assisted Physical Activity in Type-2 Diabetes

Study ID: NCT07350473
Start Date: 2026-12-01
End Date: 2029-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

305

Intervention / Treatment

Localized vibration

Placebo vibration

Usual care

Sponsor

University of Central Lancashire

Source: clinicaltrials.gov

Share:
Add to list

Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach

Study ID: NCT07147751
Start Date: 2026-04
End Date: 2029-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

International Extranodal Lymphoma Study Group (IELSG)

Source: clinicaltrials.gov

Share:
Add to list

Dose-response Study of Apremilast in Women and Men With Alcohol Use Disorder

Study ID: NCT07029529
Start Date: 2026-03
End Date: 2030-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Apremilast 60mg

Apremilust 90ng

Placebo

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list